Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Steve Yoder on Q3 2020 Results - Earnings Call Transcript

PIRS - Pieris Pharmaceuticals Inc. (PIRS) CEO Steve Yoder on Q3 2020 Results - Earnings Call Transcript

Pieris Pharmaceuticals Inc.
Pieris Pharmaceuticals, Inc. (PIRS) Q3 2020 Results Conference Call November 04, 2020 08:00 AM ET Company Participants Tom Bures - VP, Finance Steve Yoder - President and CEO Hitto Kaufmann - Chief Scientific Officer Shane Olwill - SVP and Head, Translational Science Conference Call Participants Joseph Thome - Cowen and Company Madhu Kumar - Baird Jonathan Miller - Evercore ISI Matt Phipps - William Blair Sharon Ofer - Sphera Fund Presentation Operator Greetings, and welcome to the Pieris Pharmaceuticals Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Tom Bures, Vice President of Finance. Please go ahead. Tom Bures Thank you. Good morning, everyone, and thank you for joining us for our

For further details see:

Pieris Pharmaceuticals, Inc. (PIRS) CEO Steve Yoder on Q3 2020 Results - Earnings Call Transcript
Stock Information
Company Name: Pieris Pharmaceuticals Inc.
Stock Symbol: PIRS
Market: NASDAQ
Website: pieris.com
Menu
PIRS PIRS Quote PIRS Short PIRS News PIRS Articles PIRS Message Board
Get PIRS Alerts

News, Short Squeeze, Breakout and More Instantly...